SIMCERE PHARMACEUTICAL GROUP, ADS
SCR
SCR was delisted on the 23rd of December, 2013.
0 hedge funds and large institutions have $0 invested in SIMCERE PHARMACEUTICAL GROUP, ADS in 2014 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 12 closing their positions.
100% less funds holding
Funds holding: 12 → 0 (-12)
100% less capital invested
Capital invested by funds: $3.23M → $0 (-$3.23M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 12
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG Americas Securities
New York
|
-$1.29M |
| 2 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
-$1.05M |
| 3 |
LOM
Loeb Offshore Management
New York
|
-$488K |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$236K |
| 5 |
Barclays
London,
United Kingdom
|
-$97K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
SG Americas Securities
New York
| – | -$1.29M | -134,813 | Closed |
|
|
COPPSERS
2
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
| – | -$1.05M | -109,723 | Closed |
|
|
LOM
3
Loeb Offshore Management
New York
| – | -$488K | -50,575 | Closed |
|
|
4
Baillie Gifford & Co
Edinburgh,
United Kingdom
| – | -$236K | -24,400 | Closed |
|
|
5
Barclays
London,
United Kingdom
| – | -$97K | -10,758 | Closed |
|
|
U
6
UBS
Zurich,
Switzerland
| – | -$22K | -2,248 | Closed |
|
7
Group One Trading
Chicago,
Illinois
| – | -$17K | -1,800 | Closed |
|
8
Bank of America
Charlotte,
North Carolina
| – | -$14K | -1,500 | Closed |
|
9
Morgan Stanley
New York
| – | -$11K | -1,143 | Closed |
|
10
US Bancorp
Minneapolis,
Minnesota
| – | -$2K | -196 | Closed |
|
SCR Hedge Fund Activity: Q1 2014 in Review
0 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) for Q1 2014, worth a combined $0 — down 100% from $3.23M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of SCR and 0 opened new positions — a net loss of 12 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was SG Americas Securities, exiting entirely with an estimated $1.29M sold.
- 0 institutional investors held SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) as of Q1 2014, down from 12 in Q4 2013.
- Funds reported $0 of SIMCERE PHARMACEUTICAL GROUP, ADS stock for Q1 2014, down 100% quarter-over-quarter.
- 0 funds opened new SIMCERE PHARMACEUTICAL GROUP, ADS positions in Q1 2014 and 12 closed out, a net change of -12 holders.
- The largest SIMCERE PHARMACEUTICAL GROUP, ADS seller in Q1 2014 was SG Americas Securities, an estimated $1.29M sold.
Based on aggregated 13F filings for Q1 2014.